Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High Intensity Focused Ultrasound in Prostate Cancer

NCT: NCT06402357 · RECRUITING

NCT IDNCT06402357
StatusRECRUITING
Start Date2025-05-14
Completion2029-08
SponsorUniversity of Florida (OTHER)
First posted
Last updated

Brief Summary

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also investigate the change in participant quality of life after HIFU therapy as compared to before HIFU therapy.

Frequently Asked Questions

What is High Intensity Focused Ultrasound in Prostate Cancer?

High Intensity Focused Ultrasound in Prostate Cancer is a clinical trial registered under NCT06402357. Current status: RECRUITING.

What is the status of NCT06402357?

The current status of NCT06402357 (High Intensity Focused Ultrasound in Prostate Cancer) is: RECRUITING.

When did High Intensity Focused Ultrasound in Prostate Cancer start?

High Intensity Focused Ultrasound in Prostate Cancer started on 2025-05-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.